Device Trial Radar · NCT05553158
Study to Investigate the Influence of Compression Treatment in Patients With Pelvic Congestion Syndrome (PCS)
Last checked: Nov 20, 2026Latest source record: Sep 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
172
Planned (sponsor's estimate)
Start
Nov 1, 2022
Primary completion
Nov 2024
Study completion Nov 2024
Sponsor
- Lead sponsor
- The Whiteley ClinicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Bauerfeind
- First posted
- Sep 23, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Pelvic vein embolization (PVE) is the current treatment procedure used to treat women with Pelvic Congestion Syndrome (PCS). This treatment is not widely available, and many women when diagnosed with PCS cannot afford treatment. The purpose of this study is to assess whether compression therapy is an effective alternative treatment to PVE for women who are unwilling or unable to undergo treatment by PVE. Compression therapy would provide a cost-effective alternative to coil embolization.
Conditions
- Pelvic Congestive Syndrome
Interventions
Compression pantsDevice
Similar to compression stockings for the legs which are designed to apply pressure to improve venous return in the legs, compression pants have been designed to apply pressure to pelvic veins to improve the symptoms of Pelvic Congestion Syndrome.
Embolization coilsDevice
Embolization coils are used to block the veins they are positioned in. This is a standard treatment offered to patients at The Whiteley Clinic.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change from Baseline in Quality of Life and Symptoms at one month post-treatment and at two months post-treatmentTime frame: Baseline (start of month 0), 1 month post-treatment (end of Month 2) and two months post-treatment (end of month 3)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Whiteley Clinic
Guildford, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.